1. Home
  2. LYRA vs EDTK Comparison

LYRA vs EDTK Comparison

Compare LYRA & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • EDTK
  • Stock Information
  • Founded
  • LYRA 2005
  • EDTK 2013
  • Country
  • LYRA United States
  • EDTK China
  • Employees
  • LYRA N/A
  • EDTK N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • EDTK Other Consumer Services
  • Sector
  • LYRA Health Care
  • EDTK Real Estate
  • Exchange
  • LYRA Nasdaq
  • EDTK Nasdaq
  • Market Cap
  • LYRA 15.0M
  • EDTK 14.7M
  • IPO Year
  • LYRA 2020
  • EDTK 2020
  • Fundamental
  • Price
  • LYRA $9.15
  • EDTK $0.90
  • Analyst Decision
  • LYRA Buy
  • EDTK
  • Analyst Count
  • LYRA 2
  • EDTK 0
  • Target Price
  • LYRA $16.00
  • EDTK N/A
  • AVG Volume (30 Days)
  • LYRA 288.0K
  • EDTK 7.5K
  • Earning Date
  • LYRA 08-13-2025
  • EDTK 08-18-2025
  • Dividend Yield
  • LYRA N/A
  • EDTK N/A
  • EPS Growth
  • LYRA N/A
  • EDTK N/A
  • EPS
  • LYRA N/A
  • EDTK N/A
  • Revenue
  • LYRA $1,185,000.00
  • EDTK $624,365.00
  • Revenue This Year
  • LYRA N/A
  • EDTK N/A
  • Revenue Next Year
  • LYRA $1,286.17
  • EDTK N/A
  • P/E Ratio
  • LYRA N/A
  • EDTK N/A
  • Revenue Growth
  • LYRA N/A
  • EDTK N/A
  • 52 Week Low
  • LYRA $3.81
  • EDTK $0.80
  • 52 Week High
  • LYRA $37.50
  • EDTK $1.27
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 44.26
  • EDTK 47.23
  • Support Level
  • LYRA $8.35
  • EDTK $0.80
  • Resistance Level
  • LYRA $9.36
  • EDTK $0.95
  • Average True Range (ATR)
  • LYRA 1.25
  • EDTK 0.06
  • MACD
  • LYRA -0.72
  • EDTK -0.00
  • Stochastic Oscillator
  • LYRA 9.95
  • EDTK 41.48

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About EDTK Skillful Craftsman Education Technology Limited

Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.

Share on Social Networks: